You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1406 A novel PTK7-directed antibody-drug conjugate (ADC) PRO1107 demonstrated broad antitumor activity with a promising safety profile in preclinical models

Citation Tools

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Other
1406 A novel PTK7-directed antibody-drug conjugate (ADC) PRO1107 demonstrated broad antitumor activity with a promising safety profile in preclinical models

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Xiao Y, Wang L, Liu H, et al
1406 A novel PTK7-directed antibody-drug conjugate (ADC) PRO1107 demonstrated broad antitumor activity with a promising safety profile in preclinical models
Journal for ImmunoTherapy of Cancer 2023;11:doi: 10.1136/jitc-2023-SITC2023.1406